Cargando…
Epidermal growth factor receptor inhibitors related trichomegaly of Eyelashes
Advances in understanding of the mechanisms involved in oncogenesis have led to the development of targeted therapies such as epidermal growth factor receptor inhibitors (EGFRIs), targeting a variety of molecular structures and able to inhibit aberrantly activated oncogenic pathways. Their use made...
Autores principales: | Maka, Vinayak V., Rajanna, Hithashree, Narasiyappah, Anil Kumar, Chitrapur, Rohith, Kilara, Nalini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360295/ https://www.ncbi.nlm.nih.gov/pubmed/25988043 http://dx.doi.org/10.1093/omcr/omu038 |
Ejemplares similares
-
Eyelash Trichomegaly
por: Kaur, Sandeep, et al.
Publicado: (2015) -
Essential Trichomegaly of the Eyelashes
por: Fernández-Crehuet, Pablo, et al.
Publicado: (2016) -
Erlotinib Induced Trichomegaly of the Eyelashes
por: Jeon, Sang-Hoon, et al.
Publicado: (2013) -
Acute interstitial lung disease in a patient with anaplastic lymphoma kinase-positive non-small-cell lung cancer after crizotinib therapy
por: Maka, Vinayak V., et al.
Publicado: (2014) -
Trichomegaly of Eyelashes after Treatment with Erlotinib in Carcinoma Pancreas
por: Goel, Varun, et al.
Publicado: (2014)